Private equity firm focused on lower-middle-market healthcare services and life sciences companies, typically deploying growth and buyout capital to regional operators and specialty services. The firm targets revenue and EBITDA-accretive platforms that benefit from consolidation, regulatory complexity, and recurring payor relationships. Investment approach emphasizes operational partnership, roll-up strategies, and clinical management support to drive margin expansion and scale prior to exit to strategic buyers or larger PE sponsors.
Private equity firm focused on lower-middle-market healthcare services and life sciences companies, typically deploying growth and buyout capital to regional operators and specialty services. The firm targets revenue and EBITDA-accretive platforms that benefit from consolidation, regulatory complexity, and recurring payor relationships. Investment approach emphasizes operational partnership, roll-up strategies, and clinical management support to drive margin expansion and scale prior to exit to strategic buyers or larger PE sponsors.
Targets lower‑middle‑market healthcare services and life sciences businesses, deploying growth and buyout capital to regional operators and specialty services. Prioritizes platform investments that can scale through roll‑ups, clinical operations optimization, and payer relationship stabilization. Underwriting emphasizes recurring revenue, regulatory defensibility, and EBITDA-accretive add‑ons. Capital deployment combines operational partnership and board-level clinical governance to expand margins and exit to strategic buyers or larger sponsors.
Targets lower‑middle‑market healthcare services and life sciences businesses, deploying growth and buyout capital to regional operators and specialty services. Prioritizes platform investments that can scale through roll‑ups, clinical operations optimization, and payer relationship stabilization. Underwriting emphasizes recurring revenue, regulatory defensibility, and EBITDA-accretive add‑ons. Capital deployment combines operational partnership and board-level clinical governance to expand margins and exit to strategic buyers or larger sponsors.
| Trades 963 | Longs Won 684/963 71% | Profit Factor 3.74 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $311,808.83 |
| Average Win $55,112.58 | Best Trade (Aug 14) $6.25M | Sharpe Ratio -14.51 |
| Average Loss -$36,116.4 | Worst Trade (Dec 31) -$6.6M | Z-Score 13.49 (100%) |
| Commissions $0 | Avg. Trade Length 10m 1w 1d | Expectancy $28,753.49 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 6,757 | 6,081 | 5,405 | 4,730 | 4,054 | 3,378 | 2,703 | 2,027 | 1,351 | 676 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 13,171 | $3.3M | $4.07M | - | $769,379.63 | 23.32% | -7.354% |
ABBV AbbVie Inc. | 1,184 | $246,282.43 | $297,112.96 | - | $50,830.53 | 20.64% | -2.513% |
AGCO AGCO Corporation | 1,699 | $175,298.2 | $173,569.84 | - | -$1,728.36 | -0.99% | -4.639% |
AGG iShares Core U.S. Aggregate Bond ETF | 49,180 | $4.81M | $4.79M | - | -$26,176.01 | -0.54% | -0.256% |
AMAT Applied Materials, Inc. | 926 | $189,786.29 | $470,102.43 | - | $280,316.14 | 147.7% | +1.176% |
AMD Advanced Micro Devices, Inc. | 812 | $471,699 | $386,633.79 | - | -$85,065.21 | -18.03% | -1.904% |
AMLP Alerian MLP ETF | 5,276 | $255,382 | $291,868.32 | - | $36,486.32 | 14.29% | +0.894% |
AMZN Amazon.com Inc | 5,695 | $1.25M | $1.55M | - | $296,076.23 | 23.68% | +15.321% |
ARCC Ares Capital Corporation | 30,320 | $652,581.86 | $568,803.2 | - | -$83,778.66 | -12.84% | -0.372% |
AVGO Broadcom Inc. | 4,407 | $1.19M | $1.72M | - | $528,434.07 | 44.51% | +0.371% |
BAC Bank of America Corporation | 8,326 | $368,379.05 | $515,795.7 | - | $147,416.65 | 40.02% | +0.356% |
BHP BHP Group Ltd. | 3,685 | $223,077.42 | $311,345.65 | - | $88,268.23 | 39.57% | -1.641% |
BKLN Invesco Senior Loan ETF | 36,902 | $769,456.08 | $752,431.78 | - | -$17,024.3 | -2.21% | +0.049% |
BOTZ Global X Robotics & Artificial Intelligence ETF | 11,139 | $358,760.06 | $392,315.58 | - | $33,555.52 | 9.35% | +0.917% |
BRK-B Berkshire Hathaway Inc. | 7,001 | $3.18M | $3.58M | - | $399,599.25 | 12.56% | +0.365% |
BX Blackstone Inc. | 14,905 | $2.45M | $1.9M | - | -$548,673.87 | -22.37% | -0.25% |
CAOS Alpha Architect Tail Risk ETF | 8,520 | $757,898.02 | $770,719.2 | - | $12,821.18 | 1.69% | -0.055% |
CASY Casey's General Stores Inc. | 704 | $280,949.41 | $613,184 | - | $332,234.59 | 118.25% | +0.403% |
CAT Caterpillar Inc. | 646 | $241,392.24 | $526,367.26 | - | $284,975.02 | 118.05% | +0.701% |
CBU Community Bank System, Inc. | 2,998 | $201,197 | $194,300.38 | - | -$6,896.62 | -3.43% | -0.415% |